# Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice

> **NCT02255266** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 1788 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** liraglutide

## Key facts

- **NCT ID:** NCT02255266
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-26
- **Primary completion:** 2015-11-16
- **Final completion:** 2015-11-16
- **Target enrollment:** 1788 (ACTUAL)
- **Last updated:** 2018-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02255266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02255266, "Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02255266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*